Outset Medical, Inc. (OM) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Outset Medical, Inc. (OM) closed at USD 3.84 on 2026-10-14, a change of -73 % over the past year, with a market capitalization of USD 76.69M.

Outset Medical, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Outset Medical, Inc. key figures

Previous close

USD 3.84 (2026-10-14)

1-year change

-73 %

Market cap

USD 76.69M

Enterprise value

USD 33.95M

P/E ratio (trailing)

-1.01

P/E ratio (forward)

-1.78

EPS (trailing)

-4.05

EPS (forward)

-2.29

PEG ratio

n/a

Price to book

0.80

Revenue growth

0.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.73

Employees

310

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Outset Medical, Inc. and compare it with other stocks.